04:53 PM EST, 11/22/2024 (MT Newswires) -- Lonnel Coats, Director, on November 20, 2024, sold 19,824 shares in Blueprint Medicines ( BPMC ) for $1,869,658. Following the Form 4 filing with the SEC, Coats has control over a total of 2,242 shares of the company, with 2,242 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588924027545/xslF345X05/form4-11222024_091148.xml